User profiles for "author:Mario Corbellino"
Mario CorbellinoIII Division of Infectious Diseases, FBF-Sacco Hospital, Milan, Italy Verified email at unimi.it Cited by 9503 |
Leishmaniasis among organ transplant recipients
S Antinori, A Cascio, C Parravicini… - The Lancet infectious …, 2008 - thelancet.com
Leishmaniasis is a rarely reported disease among transplant recipients; however, the
number of published cases has quadrupled since the beginning of the 1990s. Most cases …
number of published cases has quadrupled since the beginning of the 1990s. Most cases …
Candidemia and invasive candidiasis in adults: A narrative review
S Antinori, L Milazzo, S Sollima, M Galli… - European journal of …, 2016 - Elsevier
Candidemia and invasive candidiasis are major causes of morbidity and mortality, and their
incidence is increasing because of the growing complexity of patients. Five species of …
incidence is increasing because of the growing complexity of patients. Five species of …
Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV …
S Antinori, S Calattini, E Longhi… - Clinical infectious …, 2007 - academic.oup.com
Background. To overcome some of the limitations of conventional microbiologic techniques,
polymerase chain reaction (PCR)-based assays are proposed as useful tools for the …
polymerase chain reaction (PCR)-based assays are proposed as useful tools for the …
[HTML][HTML] Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
L Carsana, A Sonzogni, A Nasr, RS Rossi… - The Lancet infectious …, 2020 - thelancet.com
Background COVID-19 is characterised by respiratory symptoms, which deteriorate into
respiratory failure in a substantial proportion of cases, requiring intensive care in up to a …
respiratory failure in a substantial proportion of cases, requiring intensive care in up to a …
Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients
J Stebbing, V Krishnan, S de Bono… - EMBO molecular …, 2020 - embopress.org
Baricitinib is an oral Janus kinase (JAK) 1/JAK 2 inhibitor approved for the treatment of
rheumatoid arthritis (RA) that was independently predicted, using artificial intelligence (AI) …
rheumatoid arthritis (RA) that was independently predicted, using artificial intelligence (AI) …
[HTML][HTML] Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and …
C Parravicini, B Chandran, M Corbellino, E Berti… - The American journal of …, 2000 - Elsevier
Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is linked to KS, primary effusion
lymphomas (PEL), and a subset of multicentric Castleman's disease (MCD). Transcript …
lymphomas (PEL), and a subset of multicentric Castleman's disease (MCD). Transcript …
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
C Parravinci, M Corbellino, M Paulli… - The American journal …, 1997 - ncbi.nlm.nih.gov
Castleman's disease is a rare B cell lymphoproliferative disorder related to excess
interleukin-6 (IL-6)-like activity. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) …
interleukin-6 (IL-6)-like activity. Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) …
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post …
S Antinori, MV Cossu, AL Ridolfo, R Rech… - Pharmacological …, 2020 - Elsevier
SARS-CoV-2 is causing an increasing number of deaths worldwide because no effective
treatment is currently available. Remdesivir has shown in vitro activity against coronaviruses …
treatment is currently available. Remdesivir has shown in vitro activity against coronaviruses …
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
V Morena, L Milazzo, L Oreni, G Bestetti… - European journal of …, 2020 - Elsevier
Background Tocilizumab, a humanized monoclonal antibody, targets IL-6 receptors blocking
downstream pro-inflammatory effects of IL-6. In preliminary reports it was suggested to be …
downstream pro-inflammatory effects of IL-6. In preliminary reports it was suggested to be …
[HTML][HTML] Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19
JT Sims, V Krishnan, CY Chang, SM Engle… - Journal of Allergy and …, 2021 - Elsevier
Background Physicians treating patients with coronavirus disease 2019 (COVID-19)
increasingly believe that the hyperinflammatory acute stage of COVID-19 results in a …
increasingly believe that the hyperinflammatory acute stage of COVID-19 results in a …